Portfolio comparison
Curevac SE vs Dexcom
Side-by-side portfolio analysis — patents indexed, year ranges, and activity timeline.
Company A
Curevac SE
Patents indexed
2
Year range
2024
Most recent
2024
biotechpharmaceuticaloncologygene_editingimmunotherapy
Top Patents2 enriched
US 12048738· 2024
Using mRNA to Teach the Body to Fight Prostate Cancer
US 12083190· 2024
How an mRNA Vaccine Teaches Your Body to Fight Rabies
Activity by Decade
2020s2
Company B
Dexcom
Patents indexed
3
Year range
2016 – 2022
Most recent
2022
softwarebiotechtelecommunicationsconsumer_electronicsmedical_devices
Top Patents3 enriched
US 9282925· 2016
How Glucose Sensors Check Their Own Reliability for Insulin Pumps
US 11382539· 2022
A Catheter That Measures Glucose While Delivering Medication
US 20230263439
How a Sensor Checks Itself for Accuracy Using Other Body Data
Activity by Decade
2010s1
2020s1
How to use
Bookmark a comparison URL to save it. Format: /compare/companies?a=[slug]&b=[slug]. Also see patent-level comparison.